Patients with axSpA and IBD had higher levels of disease activity, as assessed by ESR and CRP and ET-1 levels, than did patients with axSpA without IBD, suggesting that the differences were due to IBD activity rather than arthritis activity. The gene discussed is CRP; the disease is arthritic joint disease.